Submission Deadline: 30 November 2023 (Status: Open)
Special Issue Editor
Dr. Yadu Nandan Dey Email | Website
Dr. B. C. Roy College of Pharmacy and Allied Health Sciences, Durgapur, West Bengal, India
Interests: toxicity studies; preclinical studies; herbal drug development; ethnopharmacology; diabetes; urolithiasis; arthritis; inflammation; network pharmacology; molecular docking
Special Issue Information
Although there has been marked advancement of modern medicine, traditional herbal medicine is still the primary form of treating diseases in the majority of people in developing countries and even among those where western medicine is available. In recent years, there has been a tremendous increase in the world population who uses complementary or alternative medicine. The increase in the knowledge of metabolic processes has led to molecular studies elucidating the molecular mechanisms of herbal medicines and pharmacological networks to predict the synergistic effect of the multiple components of herbal drugs. Interestingly, the demands of the market for medicinal herbs are likely to remain high because many natural products or phytoconstituents in medicinal plants cannot yet be synthesized. Most herbal preparations are free from adverse effects. Herbal medicine provides a rational treatment of many disease or conditions which are difficult to treat or incurable in other types of treatment, such as allopathic medicine.
This topic of the Special Issue is focused on gathering original research on herbal drugs and natural products, including phytochemical studies, in silico network pharmacology and molecular docking studies, in vitro assays, including the use of cell lines, and in vivo preclinical toxicological and pharmacological studies, along with molecular studies of plant extracts and natural products. Reviews on herbal medicine and natural product research are also within the scope of this special issue.
Yadu Nandan Dey
natural product; medicinal plants; herbal drug development; ethnopharmacology; preclinical studies; toxicity studies; in silico studies; network pharmacology; in vitro studies
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://www.biolifesas.org/journalx_brha/authorLogOn.action by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. Submitted manuscripts should be well formatted in good English.